T-bet overexpression enhances CAR T cell effector functions and antigen sensitivity
Background T cells modified to express a chimeric antigen receptor (CAR) are successful against B-lineage malignancies but fail to induce durable remissions in up to half of patients and have shown limited efficacy against other types of cancer. Strategies to improve CAR T cell potency and responses...
Saved in:
| Main Authors: | M. Eric Kohler, Kole R DeGolier, Terry J Fry, Amalia M Rivera-Reyes, Jennifer M Cimons, Samuel D Burciaga, Michael C Yarnell, Amanda J Novak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-04-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/4/e010962.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human macrophages engineered to secrete a bispecific T cell engager support antigen-dependent T cell responses to glioblastoma
by: Shannon A Kreuser, et al.
Published: (2020-10-01) -
Is immune effector cell-associated enterocolitis a CAR T-cell lymphoproliferative disorder?
by: Kayra Somay, et al.
Published: (2025-07-01) -
The CXCL16/CXCR6 axis is linked to immune effector cell-associated neurotoxicity in chimeric antigen receptor (CAR) T cell therapy
by: I-Na Lu, et al.
Published: (2025-06-01) -
Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function
by: Marta Barisa, et al.
Published: (2025-08-01) -
Analysis of Mitochondrial Function in Antigen Specific na ve, Effector and MEmory CD8 + T Cells
by: Jason M. Grayson, et al.
Published: (2001-01-01)